Akero Therapeutics Inc (AKRO)
31.22
+0.58
(+1.91%)
USD |
NASDAQ |
Nov 21, 16:00
31.22
0.00 (0.00%)
After-Hours: 20:00
Akero Therapeutics Price to Book Value: 2.951 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 2.896 |
| November 19, 2024 | 2.934 |
| November 18, 2024 | 2.794 |
| November 15, 2024 | 2.656 |
| November 14, 2024 | 2.813 |
| November 13, 2024 | 2.928 |
| November 12, 2024 | 3.061 |
| November 11, 2024 | 3.124 |
| November 08, 2024 | 3.257 |
| November 07, 2024 | 3.296 |
| November 06, 2024 | 3.335 |
| November 05, 2024 | 3.095 |
| November 04, 2024 | 3.030 |
| November 01, 2024 | 3.056 |
| October 31, 2024 | 2.915 |
| October 30, 2024 | 2.895 |
| October 29, 2024 | 2.992 |
| October 28, 2024 | 2.801 |
| October 25, 2024 | 2.765 |
| October 24, 2024 | 2.711 |
| October 23, 2024 | 2.703 |
| October 22, 2024 | 2.79 |
| October 21, 2024 | 2.914 |
| October 18, 2024 | 2.945 |
| October 17, 2024 | 2.906 |
| Date | Value |
|---|---|
| October 16, 2024 | 2.928 |
| October 15, 2024 | 2.822 |
| October 14, 2024 | 2.830 |
| October 11, 2024 | 2.794 |
| October 10, 2024 | 2.742 |
| October 09, 2024 | 2.688 |
| October 08, 2024 | 2.654 |
| October 07, 2024 | 2.522 |
| October 04, 2024 | 2.663 |
| October 03, 2024 | 2.607 |
| October 02, 2024 | 2.754 |
| October 01, 2024 | 2.718 |
| September 30, 2024 | 2.705 |
| September 27, 2024 | 2.457 |
| September 26, 2024 | 2.552 |
| September 25, 2024 | 2.436 |
| September 24, 2024 | 2.440 |
| September 23, 2024 | 2.468 |
| September 20, 2024 | 2.443 |
| September 19, 2024 | 2.436 |
| September 18, 2024 | 2.346 |
| September 17, 2024 | 2.318 |
| September 16, 2024 | 2.329 |
| September 13, 2024 | 2.378 |
| September 12, 2024 | 2.236 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.087
Minimum
Oct 27 2023
12.74
Maximum
Jul 27 2020
4.349
Average
3.820
Median
Price to Book Value Benchmarks
| Madrigal Pharmaceuticals Inc | 9.238 |
| 89bio Inc | 2.606 |
| NovaBay Pharmaceuticals Inc | 3.291 |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.263 |
Price to Book Value Related Metrics
| Price | 31.22 |
| Earnings Yield | -12.11% |
| Market Cap | 2.179B |